
PhaseV Secures $50 Million in Funding for AI-Driven Clinical Trial Solutions
PhaseV secures $50 million for AI-driven clinical trial solutions, enhancing efficiency in biopharma and CRO operations. π°π€
Discover the newest research about AI innovations in π§ Digital Therapeutics.
PhaseV secures $50 million for AI-driven clinical trial solutions, enhancing efficiency in biopharma and CRO operations. π°π€
“Digital Health Curriculum Boosts Student Competence π: 65% Women, 1.8 Mean Increase in Robotics Skills!” π€
AI predicts pediatric brain cancer relapse with 75-89% accuracy, improving care for children with gliomas. π§ π
TSOLife raises $43 million for its AI platform, Minerva, enhancing senior living through data-driven insights and community connections. π‘π
iPiDA-LGE enhances piRNA-disease association detection using local and global graph learning. ππ¬ Improved predictive performance noted!
Cedars-Sinai and Redesign Health are collaborating on a digital health initiative to enhance patient care and operational efficiency. π₯π»
AI-powered medical devices are enhancing healthcare delivery through early disease detection and real-time monitoring. π©Ίπ
EMC Healthcare in Indonesia is upgrading to an AI-driven EMR system, enhancing patient care and clinical efficiency. π₯π€
Atropos Health partners with Ontada to enhance oncology data use, improving patient care and treatment protocols. ππ
Revolutionizing Vital Sign Monitoring: Comestai App’s Non-contact Methodology π±π